{
    "Trade/Device Name(s)": [
        "NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352)"
    ],
    "Submitter Information": "Biotest Medical Corporation",
    "510(k) Number": "K171822",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141351"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "August 17, 2017",
    "Summary Letter Received Date": "August 21, 2017",
    "Submission Date": "September 11, 2017",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NuvoMed Wireless Blood Glucose Monitor (Model BGM-6/0352)"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection (FAD-glucose dehydrogenase)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strip",
        "Lancing device",
        "Lancet",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for NuvoMed Wireless Blood Glucose Monitoring System (Model BGM-6/0352) featuring Bluetooth data transmission and intended for self-monitoring of blood glucose by people with diabetes",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip or forearm by a single person for self-testing at home as an aid in monitoring effectiveness of a diabetes control program; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}